WNT5B驱动骨髓瘤的干度,化学抵抗和转移
Rachel S Perkins1,2, Glenn Murray3,4, Sarocha Suthon1
1Department of Orthopaedic Surgery and Biomedical Engineering, University of Tennessee Health Science Center, Memphis, Tennessee, USA.
Clinical and translational medicine
|May 1, 2024
概括
WNT5B驱动骨髓瘤干细胞生长和甲状腺素耐药性,促进转移. 用ROR1抗体向WNT5B/ROR1通路可能为骨髓瘤患者提供新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症干细胞研究研究
背景情况:
- 骨髓瘤治疗缺乏进展,目标治疗有限.
- 转移性骨肉瘤的5年生存率很差 (20%).
- 在骨髓瘤中,WNT5B的表达与转移和减少存活率相关.
研究的目的:
- 研究WNT5B在骨髓瘤类干细胞中的作用.
- 确定WNT5B对转移和化学抵抗的影响.
- 评估WNT5B作为潜在的治疗点.
主要方法:
- 利用瘤球体来建模癌症干细胞.
- 进行了基因/蛋白质分析的qPCR,免疫阻塞和免疫光.
- 评估球体大小,迁移和形成效率,以监测表型变化.
主要成果:
- 在骨髓瘤干细胞中富含WNT5B,诱导SOX2表达.
- WNT5B促进球体生长,扩散,迁移和甲基抗性.
- WNT5B通过调节HYAL1,降解氨酸来增强肺/肝转移.
- WNT5B与ROR1相关;ROR1抗体的抑制降低了树干性和化学抵抗性.
结论:
- WNT5B驱动骨髓瘤干细胞扩张和甲状腺素耐药性.
- WNT5B通路是骨髓瘤的一个有前途的治疗点.
- 用ROR1抗体准WNT5B/ROR1信号,可以降低骨髓瘤的干度.
相关概念视频
Canonical Wnt Signaling Pathway
8.7K
The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
8.7K
Non-Canonical Wnt Signaling Pathways
7.3K
Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
7.3K
Cancer Stem Cells and Tumor Maintenance
4.9K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.9K
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K


